Publications by authors named "Philip Disaia"

Claim this Profile
P
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study.
Larry J Copeland, Mark F Brady, Robert A Burger, William H Rodgers, Helen Q Huang, Philip J DiSaia

J Clin Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.
Krishnansu S Tewari, Robert A Burger, Danielle Enserro, Barbara M Norquist, Elizabeth M Swisher, Philip J DiSaia

J Clin Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
Krishnansu S Tewari, Michael W Sill, Richard T Penson, Helen Huang, Lois M Ramondetta, Philip J DiSaia

Lancet· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NRG Oncology research opportunities within the new National Clinical Trials Network.
Walter J Curran, Philip J DiSaia, Norman Wolmark

Semin Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of high-dose-rate interstitial brachytherapy in the treatment of locally advanced cervical cancer: long-term results.
Melva Pinn-Bingham, Ajmel A Puthawala, A M Nisar Syed, Anil Sharma, Philip Disaia

Int J Radiat Oncol Biol Phys· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fertility preserving options in patients with gynecologic malignancies.
Ramez N Eskander, Leslie M Randall, Michael L Berman, Krishnansu S Tewari, Philip J Disaia

Am J Obstet Gynecol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent endometrial stromal sarcoma: treatment with a progestin and gonadotropin releasing hormone agonist.
Nefertiti Chianti Dupont, Philip John Disaia

Sarcoma· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line therapy in ovarian cancer trials.
Tate Thigpen, Andreas duBois, Jessica McAlpine, Philip DiSaia, Keiichi Fujiwara

Int J Gynecol Cancer· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting parametrial involvement in endometrial cancer: is this the end for radical hysterectomies in stage II endometrial cancers?
Philip J Disaia

Obstet Gynecol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hormone replacement and breast cancer risk: reconsidering the data.
William T Creasman, Philip J DiSaia

Oncology (Williston Park)· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colposcopy to evaluate abnormal cervical cytology in 2008.
Dana M Chase, Marlene Kalouyan, Philip J DiSaia

Am J Obstet Gynecol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Node count and groin recurrence in early vulvar cancer: A Gynecologic Oncology Group study.
Frederick B Stehman, Shamshad Ali, Philip J DiSaia

Gynecol Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis.
John K Chan, Valerie Sugiyama, Huyen Pham, Mai Gu, Joanne Rutgers, Philip J Disaia

Gynecol Oncol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer.
John K Chan, Alessandra Magistris, Vera Loizzi, Fritz Lin, Joanne Rutgers, Philip J DiSaia

Gynecol Oncol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conservation of in vitro drug resistance patterns in epithelial ovarian carcinoma.
Krishnansu S Tewari, Rita S Mehta, Robert A Burger, Ing-Ru Yu, Ainura S Kyshtoobayeva, Philip J Disaia

Gynecol Oncol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic features of six cases of primary cervical lymphoma.
John K Chan, Vera Loizzi, Alessandra Magistris, Mark I Hunter, Joanne Rutgers, Philip J DiSaia

Am J Obstet Gynecol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat model.
John K Chan, Huyen Pham, Xue Juan You, Noelle G Cloven, Robert A Burger, Philip J Disaia

Cancer Res· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.
John K Chan, Mallory Zhang, Vanessa Kaleb, Vera Loizzi, Jacqueline Benjamin, Philip J Disaia

Gynecol Oncol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in prognostic molecular markers between women over and under 45 years of age with advanced ovarian cancer.
John K Chan, Vera Loizzi, Alessandra Magistris, Fritz Lin, Joanne Rutgers, Philip J Disaia

Clin Cancer Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy: a gynecologic oncology group study.
Robert A Burger, Kathleen M Darcy, Philip J DiSaia, Bradley J Monk, Elizabeth A Grosen

Cancer· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified technique for suprapubic catheter insertion that avoids urinary leakage.
Michael L Berman, Thanh H Truong, Philip J DiSaia, John K Chan

Am J Obstet Gynecol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapy.
Vera Loizzi, John K Chan, Kathryn Osann, Fabio Cappuccini, Philip J DiSaia

Am J Obstet Gynecol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
John K Chan, Yvonne G Lin, Vera Loizzi, Mariam Ghobriel, Philip J DiSaia

J Reprod Med· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the proper extent of an inguinal lymphadenectomy for early vulvar cancer?
Philip J DiSaia

Gynecol Oncol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WHI: Now that the dust has settled: a commentary.
William T Creasman, David Hoel, Philip J Disaia

Am J Obstet Gynecol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis